The purchase price of adagrasib (Krazati) in Hong Kong and the precautions for cross-border drug purchase

As a new type of KRAS inhibitor, adagrasib (Krazati) is not currently on the market in China. Therefore, if domestic patients need to use the drug, they can only purchase it through regular overseas channels. Among them, Hong Kong is one of the more common channels for cross-border drug purchase. When patients purchase adagrasib at a Hong Kong pharmacy, they can choose the American original version or the Laotian generic version. The U.S. version of the original drug is very expensive, with the price per box likely to be as high as hundreds of thousands of yuan. However, the Laotian generic drug is relatively cheap, with a price of about more than 3,000 yuan per box, and the drug ingredients are basically the same as the original drug, which can provide a viable option for patients with limited financial conditions.

During the process of cross-border drug purchase, patients need to pay attention to the formal sources of drugs and ensure that the purchase channels are legal and reliable. It is recommended to purchase through certified Hong Kong pharmacies or international medical procurement platforms, and avoid obtaining drugs through unknown channels or private drug purchases to prevent the purchase of counterfeit drugs or drugs with quality issues. In addition, when purchasing drugs, patients should confirm that the drug packaging is complete and the drug has an adequate validity period, and carefully check the drug ingredients and information on the instructions to ensure that it is consistent with the prescriptions prescribed by domestic doctors.

When purchasing adagrasib, patients should also pay attention to transportation and storage conditions. Since the drug is an oral small molecule preparation, it should generally avoid high temperature and humid environments. At the same time, the integrity of the drug should be maintained during transportation to prevent packaging damage or moisture. In addition, when transporting across borders, it is necessary to pay attention to relevant customs policies and drug declaration regulations to ensure that drugs can be carried or mailed into the country smoothly to avoid unusable drugs due to illegal operations.

Finally, while using adagrasib, patients should strictly follow the doctor’s instructions and follow the dosage and treatment requirements. Although drugs can be obtained through cross-border purchases, drug safety still needs to be paid attention to, including regular review, monitoring of blood routine and liver and kidney function, and observation of adverse reactions. At the same time, patients should maintain communication with their domestic attending doctors and provide timely feedback on drug effects and possible adverse reactions in order to adjust treatment plans and ensure drug safety and maximize efficacy.

Reference materials:https://www.drugs.com/